News
Merck Life Science South Africa, a leading science and technology company, is excited to announce its participation as a bronze sponsor at Analytica Lab Africa 2025. This major trade fair for ...
Merck & Co – known as MSD outside of the US and Canada – and Cyprumed have entered into a partnership aimed at developing ...
Merck signs deal with Austria's Cyprumed to develop oral peptide therapies, potentially paying up to $493 million for access ...
Merck Foundation marks World Cancer Day by providing 194 Oncology Scholarship to Doctors from 32 African Countries ...
Merck & Co. has entered a competitive race for a new type of heart drug ... president of Merck Research Laboratories, in a statement. The frontrunners in the chase, among them Novartis and ...
Merck released phase III data for an injection form of its blockbuster cancer treatment drug Keytruda and announced the FDA is reviewing the application for approval. The data sho ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
2d
MedPage Today on MSNDetectable ctDNA Before Adjuvant Therapy for Melanoma May Predict RecurrenceDroplet digital PCR measurements of circulating tumor (ct)DNA to assess minimal residual disease before the initiation of ...
The trial compared the new subcutaneous pembrolizumab ... global clinical development at Merck Research Laboratories, also highlighted the innovative approach of the subcutaneous pembrolizumab ...
Milan Kalawadia, CEO, North America, at Dr. Reddy’s Laboratories, goes inside the company’s new growth initiatives—and ...
Li, president of Merck Research Laboratories, highlighted the significance ... Merck has inaugurated a new $1 billion vaccine manufacturing facility in Durham, North Carolina.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results